Purpose: Medical cannabis use is rising with limited high-quality clinical trial data to guide dosing. This study relies on real-world, longitudinal medical cannabis purchase data to provide information on Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) dosing trends for patients with qualifying medical conditions.
Methods: A retrospective study of purchases by 16,727 patients obtaining medical cannabis from dispensaries located in New York between 2016 and 2019, recorded in point-of-sale data.
Introduction: Cannabis use in the U.S. rose early in the COVID-19 pandemic, but it is unclear whether that rise was temporary or permanent.
View Article and Find Full Text PDFThis cross-sectional study examines the purchase of medical cannabis products made in New York State from dispensaries operated by a single integrated manufacturer and licensed retail company within the state.
View Article and Find Full Text PDFIntroduction: Vaping has become an increasingly common mode of administration for marijuana among youth, but there are limited data on its prevalence. There is a need to better understand youth prevalence of past 30-day marijuana vaping and its predictors.
Methods: Data were from a nationally representative sample of students from the Monitoring the Future survey in 2018 (N=9,131).